Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Scheltens

Showing results (191-200 of 266) with videos related to

Pageof 27
Sort By:
Alzheimer'S Research & Therapy|April 19, 2020
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodiesM van de Beek, R Babapour Mofrad, I van Steenoven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimagingY A L Pijnenburg, S N M Schoonenboom, F Barkhof, et al.
Dementia and Geriatric Cognitive Disorders|July 8, 2010
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic populationF H Bouwman, N A Verwey, M Klein, et al.
Psychological Medicine|November 20, 2014
The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI studyR Hamel, S Köhler, N Sistermans, et al.
AJNR. American Journal of Neuroradiology|June 1, 1997
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disabilityG J Lycklama à Nijeholt, F Barkhof, P Scheltens, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 10, 1999
The diagnostic value of electroencephalography in mild senile Alzheimer's diseaseJ J Claus, R L Strijers, E J Jonkman, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification PotentialS Abushakra, A Porsteinsson, P Scheltens, et al.
Neurology|September 6, 2007
Longitudinal changes of CSF biomarkers in memory clinic patientsF H Bouwman, W M van der Flier, N S M Schoonenboom, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
Neurology|November 5, 2010
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest oldT M Polvikoski, E C W van Straaten, F Barkhof, et al.
Pageof 27

Showing results (191-200 of 266) with videos related to

Sort By:
Pageof 27
Alzheimer'S Research & Therapy|April 19, 2020
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodiesM van de Beek, R Babapour Mofrad, I van Steenoven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimagingY A L Pijnenburg, S N M Schoonenboom, F Barkhof, et al.
Dementia and Geriatric Cognitive Disorders|July 8, 2010
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic populationF H Bouwman, N A Verwey, M Klein, et al.
Psychological Medicine|November 20, 2014
The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI studyR Hamel, S Köhler, N Sistermans, et al.
AJNR. American Journal of Neuroradiology|June 1, 1997
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disabilityG J Lycklama à Nijeholt, F Barkhof, P Scheltens, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 10, 1999
The diagnostic value of electroencephalography in mild senile Alzheimer's diseaseJ J Claus, R L Strijers, E J Jonkman, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification PotentialS Abushakra, A Porsteinsson, P Scheltens, et al.
Neurology|September 6, 2007
Longitudinal changes of CSF biomarkers in memory clinic patientsF H Bouwman, W M van der Flier, N S M Schoonenboom, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
Neurology|November 5, 2010
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest oldT M Polvikoski, E C W van Straaten, F Barkhof, et al.
Pageof 27